PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Pathology, Stanford University School of Medicine, 300 Pasteur Drive, Stanford, California 94305, United States.\', \'Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg 69120, Germany.\', \'German Center for Infection Research (DZIF), Heidelberg Partner Site, Heidelberg, 69120, Germany.\', \'Institute of Molecular Medicine and Cell Research, University of Freiburg, Freiburg 79110, Germany.\', \'Division Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg 69120, German.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1021/acsinfecdis.0c00815
?:doi
?:hasPublicationType
?:journal
  • ACS infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 33570381
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.618
?:rankingScore_hIndex
  • 13
is ?:relation_isRelatedTo_publication of
?:title
  • Challenges for Targeting SARS-CoV-2 Proteases as a Therapeutic Strategy for COVID-19.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/33570381>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/33570381>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all